Key points are not available for this paper at this time.
We investigated the risk of UTIs and complex UTIs associated with SGLT2 (sodium-glucose cotransporter-2) inhibitors in men, emphasizing older men at higher risk for voiding dysfunction.
Qian et al. (Fri,) studied this question.